Freenome Inc.
Organization details
- Legal name
- Freenome Inc.
- Former names
- Perceptive Capital Solutions Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Brisbane
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- FRNM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002017526
Board of directors
-
Aaron Matthew Elliott · Director · Chief Executive OfficerSince 2026
-
Adam Leo Stone · Director · Chief Executive OfficerSince 2024
-
Ann Catherine Costello · DirectorSince 2026
-
Carole Nuechterlein · DirectorSince 2026
-
Deepika Pakianathan · DirectorSince 2026
-
Harlan Waksal · DirectorSince 2024
- Since 2024
-
Kenneth Song · DirectorSince 2024
- Since 2024
-
Michael Seth Altman · Director · Chief Business OfficerSince 2024
-
Oort Douglas M. Van · DirectorSince 2026
- Since 2026
- Since 2026
-
Randal W. Scott · DirectorSince 2026
Chief executives
Board connections
9 of this board's directors also sit on 40 other boards. 37 are in the same sector.
-
Solid Biosciences Inc. Same sectorvia Adam Leo Stone, Joseph Edelman, Peter Kolchinsky and Rajeev M. Shah
-
ARS Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acrivon Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acumen Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Artiva Biotherapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bambusa Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bicara Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Black Diamond Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Climb Bio Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Evommune Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Hemab Therapeutics Holdings Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Immatics N.V. Same sectorvia Adam Leo Stone and Joseph Edelman
-
Jade Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Janux Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
LENZ Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Mineralys Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
- via Joseph Edelman and Michael Seth Altman
-
Nkarta Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Parabilis Medicines Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
PepGen Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Septerna Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Sionna Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
SpyGlass Pharma Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Tyra Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Vor Biopharma Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Wave Life Sciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Werewolf Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Adagio Medical Holdings Inc Same sectorvia Joseph Edelman
-
Aligos Therapeutics Inc. Same sectorvia Carole Nuechterlein
-
BridgeBio Oncology Therapeutics Inc. Same sectorvia Mark C. McKenna
-
BridgeBio Pharma Inc. Same sectorvia Randal W. Scott
- via Mark C. McKenna
-
Kardigan Inc. Same sectorvia Joseph Edelman
-
Karyopharm Therapeutics Inc. Same sectorvia Deepika Pakianathan
-
LeonaBio Inc. Same sectorvia Joseph Edelman
-
MeiraGTx Holdings plc Same sectorvia Joseph Edelman
-
Mereo BioPharma Group plc Same sectorvia Deepika Pakianathan
-
NewAmsterdam Pharma Company N.V. Same sectorvia Mark C. McKenna
-
Spyre Therapeutics Inc. Same sectorvia Mark C. McKenna
- via Mark C. McKenna
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 2, 2026 | Aaron Matthew Elliott Director, Officer (Chief Executive Officer) | Shares withheld for tax | −71,920 | $15.25 | $1,096,780 |
| Jul 20, 2026 | Michael Seth Altman Former Dir, Ofc, 10% Ownr | Derivative conversion | +2,066,250 | — | — |
| Jul 20, 2026 | PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% owner | Grant or award | +5,500,000 | $10.00 | $55,000,000 |
| Jul 20, 2026 | RA Capital Nexus Fund, L.P. Director | Grant or award | +6,561,711 | — | — |
| Jul 20, 2026 | Adam Leo Stone Former Dir, Ofc, 10% Ownr | Derivative conversion | +2,066,250 | — | — |
| Jul 20, 2026 | Mark C. McKenna Former Director | Derivative conversion | +30,000 | — | — |
| Jul 20, 2026 | Perceptive Capital Solutions Holdings Former 10% Owner | Derivative conversion | +2,066,250 | — | — |
| Jul 20, 2026 | Kenneth Song Former Director | Derivative conversion | +30,000 | — | — |
| Jul 20, 2026 | Harlan Waksal Former Director | Derivative conversion | +30,000 | — | — |
| Jul 20, 2026 | RA Capital Nexus Fund, L.P. Director | Grant or award | +970,950 | — | — |
| Jul 20, 2026 | RA Capital Nexus Fund, L.P. Director | Grant or award | +553,703 | — | — |
| Jul 20, 2026 | RA Capital Nexus Fund, L.P. Director | Grant or award | +908,103 | — | — |
| Jul 20, 2026 | RA Capital Nexus Fund, L.P. Director | Grant or award | +367,427 | — | — |
| Jul 20, 2026 | RA Capital Nexus Fund, L.P. Director | Grant or award | +4,918,411 | $10.00 | $49,184,110 |
| Jul 20, 2026 | RA Capital Nexus Fund, L.P. Director | Grant or award | +336,965 | $10.00 | $3,369,650 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Freenome Inc.
Who is the CEO of Freenome Inc.?
Aaron Matthew Elliott has been Freenome Inc.'s Chief Executive Officer since July 2026.
How many directors are on Freenome Inc.'s board?
Freenome Inc.'s board has 14 directors: Aaron Matthew Elliott, Adam Leo Stone, Ann Catherine Costello, Carole Nuechterlein, Deepika Pakianathan, Harlan Waksal, Joseph Edelman, Kenneth Song, Mark C. McKenna, Michael Seth Altman and 4 others.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="freenome-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.